Telix Pharmaceuticals Limited ADR (TLX) Stock Price, Quote & News

Company Profile

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3 clinical trial in patients with advanced prostate cancer. The company develops TLX250...

Industry: Biotechnology

Sector: Healthcare

Phone: 61 3 9093 3855

Website: telixpharma.com

Address:

55 Flemington Road, Level 4, North Melbourne, Australia

RadioIsotope25 Apr. 5 at 8:59 PM

There’s a really good setup here where Radiopharm could sell ex-US rights to fund the company next 24 months for RAD101 since if it can do $500 USA probably could do something similar globally. Could be the next billion dollar $TLX or $LNTH and one of those two could be buying those rights. Add on RAD202/204 and B7-H3/KLK3 and your basically in 24-36 mos looking at something very large like $AKTS Only need 1 of the therapeutics to show efficacy of the 4. Each is a billion dollar company+ opportunity.. $RADX

0 · Reply

JFais Apr. 3 at 3:03 PM

$TLX (L) One of the slides we focused on for March double-down in $6's

0 · Reply

S144 Apr. 3 at 6:14 AM

$TLX 3 reasons to buy this red-hot ASX healthcare stock today: https://www.msn.com/en-au/health/healthy-lifestyle/3-reasons-to-buy-this-red-hot-asx-healthcare-stock-today/ar-AA1ZWnTW

0 · Reply

RadioIsotope25 Mar. 31 at 4:58 PM

Nuclear Radiopharma industry is hot. All of these stocks are strong buys imo. $RADX $TLX $LNTH $AKTS $CATX

1 · Reply

JFais Mar. 28 at 1:18 PM

$TLX (L) From Weekly Recap

0 · Reply

RadioIsotope25 Mar. 27 at 1:31 AM

RAD 101 Shows 90% Primary End Point Success in Brain Metastases Trial | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways $TLX $AKTS $CATX $RADX $LNTH https://www.targetedonc.com/view/rad-101-shows-90-primary-end-point-success-in-brain-metastases-trial

1 · Reply

Cacaos Mar. 26 at 2:37 AM

$TLX 🤩

0 · Reply

alsworthg Mar. 24 at 2:53 PM

$RADX $AKTS $CATX $LNTH $TLX

0 · Reply

RadioIsotope25 Mar. 24 at 2:46 PM

Webinar Registration - Zoom $RADX $AKTS $CATX $LNTH $TLX https://us02web.zoom.us/webinar/register/WN_Uy9zCUEhQUaMqC1rYG5Zhw#/registration

0 · Reply

RadioIsotope25 Mar. 22 at 5:41 PM

Regarding RAD101 “tumors light up. We are at the cusp of a Theranostics revolution. $RADX $TLX $LNTH $AKTS

0 · Reply

Telix Appoints David Gill as Non-Executive Director

Mar 20, 2026, 2:00 AM EDT - 16 days ago

Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in the U.S.

TLX

Tue, 17 Mar 2026 19:42:20 -0400 - 19 days ago

Telix Pharmaceuticals Limited (TLX) Discusses Revenue Growth, Prostate Cancer Imaging Portfolio, and Expansion into Brain and Kidney Cancer Transcript

2026-03-16T09:41:20.000Z - 20 days ago

Telix Resubmits NDA For Brain Cancer Imaging Candidate TLX101-Px To FDA

2026-03-16T00:59:50.000Z - 21 days ago

Telix Resubmits TLX101-Px NDA To FDA For Brain Cancer Imaging Agent

Mar 15, 2026, 5:25 PM EDT - 21 days ago

Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate

TLX

2026-03-10T11:01:49.000Z - 26 days ago

Why Is Telix Pharmaceuticals Stock Gaining Tuesday?

Tue, 10 Mar 2026 00:47:58 -0400 - 26 days ago

Telix Pharmaceuticals Limited (TLX) Discusses ProstACT Global Phase 3 Study Part 1 Results and Safety Profile Transcript

Mar 9, 2026, 7:19 PM EDT - 27 days ago

ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives

TLX

Thu, 05 Mar 2026 00:42:17 -0500 - 4 weeks ago

Telix Pharmaceuticals Limited (TLX) Discusses Physician Perspectives on Innovations in PSMA PET CT Imaging for Prostate Cancer Transcript

2026-03-03T00:00:12.000Z - 4 weeks ago

Telix Pharmaceuticals Ltd at TD Cowen Healthcare Conference Transcript

Sun, 01 Mar 2026 22:00:48 -0500 - 5 weeks ago

Telix Pharmaceuticals: Scope Of Company Beyond Radio Antibody-Drug Conjugate TLX591-Tx

Feb 27, 2026, 7:00 AM EST - 5 weeks ago

Telix Joins Forces with University Hospital Essen on PROMISE-PET: Optimizing Patient Management through AI-enabled PSMA-PET Imaging

TLX

Thu, 26 Feb 2026 05:15:00 -0500 - 5 weeks ago

1 Basically Unknown Stock That Could Turn Cancer‑Imaging Breakthroughs Into Generational Wealth

2026-02-24T18:31:54.000Z - 5 weeks ago

Citigroup Raises Price Target on Telix Pharmaceuticals (TLX) to $22.50 | TLX Stock News

Fri, 20 Feb 2026 02:44:56 -0500 - 6 weeks ago

Telix Pharmaceuticals Limited (TLX) Q4 2025 Earnings Call Transcript

2026-02-20T05:04:22.000Z - 6 weeks ago

Telix Pharmaceuticals Ltd (TLPPF) Full Year 2025 Earnings Call Highlights: Robust Revenue ...

2026-02-20T04:00:11.000Z - 6 weeks ago

Full Year 2025 Telix Pharmaceuticals Ltd Earnings Call Transcript

Feb 19, 2026, 7:02 PM EST - 6 weeks ago

FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment

TLX

Feb 17, 2026, 4:55 PM EST - 6 weeks ago

Telix Submits European Marketing Authorization Application for TLX101-Px for Brain Cancer Imaging

TLX

Jan 21, 2026, 2:15 PM EST - 2 months ago

Telix Pharmaceuticals Reports Strong Full-Year Revenue, But Shares Remain Under Pressure

TLX

Mon, 12 Jan 2026 15:25:59 -0500 - 2 months ago

Telix Pharmaceuticals Limited (TLX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Fri, 09 Jan 2026 15:56:00 -0500 - 3 months ago

Levi & Korsinsky Reminds Telix Pharmaceuticals Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 – TLX

Fri, 09 Jan 2026 11:57:00 -0500 - 3 months ago

TELIX FINAL CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights

Fri, 09 Jan 2026 10:10:00 -0500 - 3 months ago

FINAL DEADLINE ALERT: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026

Fri, 09 Jan 2026 09:00:00 -0500 - 3 months ago

Telix Pharmaceuticals Ltd. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your Rights - TLX

Fri, 09 Jan 2026 06:49:00 -0500 - 3 months ago

TLX FINAL DEADLINE ALERT: Hagens Berman Alerts Telix Pharm. (TLX) Investors of Today's Lead Plaintiff Deadline in Securities Class Action

Thu, 08 Jan 2026 19:00:00 -0500 - 3 months ago

TLX Deadline Tomorrow: Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm – TLX

Thu, 08 Jan 2026 17:46:00 -0500 - 3 months ago

Telix Pharmaceuticals Ltd. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before January 9, 2026 to Discuss Your Rights – TLX

Thu, 08 Jan 2026 13:04:00 -0500 - 3 months ago

Deadline Soon: Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

Thu, 08 Jan 2026 13:00:00 -0500 - 3 months ago

Telix Pharmaceuticals (TLX) Faces Securities Class Action After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman

Thu, 08 Jan 2026 12:00:00 -0500 - 3 months ago

Bronstein, Gewirtz & Grossman LLC Urges Telix Pharmaceuticals Limited Investors to Act: Class Action Filed Alleging Investor Harm

Thu, 08 Jan 2026 11:41:00 -0500 - 3 months ago

DEADLINE TOMORROW: Berger Montague Advises Telix Pharmaceuticals Ltd. (TLX) Investors to Inquire About a Securities Fraud Class Action by January 9, 2026

Thu, 08 Jan 2026 09:00:00 -0500 - 3 months ago

Shareholders that lost money on Telix Pharmaceuticals Ltd.(TLX) should contact The Gross Law Firm about pending Class Action - TLX

Jan 8, 2026, 6:00 AM EST - 3 months ago

Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference

TLX

Wed, 07 Jan 2026 18:02:00 -0500 - 3 months ago

Telix (TLX) 2-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Wed, 07 Jan 2026 15:30:00 -0500 - 3 months ago

Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Jan 7, 2026, 11:39 AM EST - 3 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

TLX

Wed, 07 Jan 2026 09:01:00 -0500 - 3 months ago

FRIDAY DEADLINE: Berger Montague Advises Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Investors to Inquire About a Securities Fraud Class Action by January 9, 2026

Tue, 06 Jan 2026 16:00:00 -0500 - 3 months ago

Levi & Korsinsky Notifies Shareholders of Telix Pharmaceuticals Ltd. (TLX) of a Class Action Lawsuit and an Upcoming Deadline

Tue, 06 Jan 2026 15:40:00 -0500 - 3 months ago

TLX Deadline: TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm

Tue, 06 Jan 2026 10:19:00 -0500 - 3 months ago

Portnoy Law Firm Announces Class Action on Behalf of Telix Pharmaceuticals Limited Investors

Tue, 06 Jan 2026 09:00:00 -0500 - 3 months ago

Telix Pharmaceuticals Ltd. Sued for Securities Law Violations - Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your Rights - TLX

Tue, 06 Jan 2026 08:46:00 -0500 - 3 months ago

Telix Pharmaceuticals Ltd. (TLX) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

Mon, 05 Jan 2026 20:14:00 -0500 - 3 months ago

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

Mon, 05 Jan 2026 16:51:00 -0500 - 3 months ago

TELIX URGENT CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights Before January 9th

Mon, 05 Jan 2026 09:09:00 -0500 - 3 months ago

Telix (TLX) 4-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Mon, 05 Jan 2026 09:00:00 -0500 - 3 months ago

Investors in Telix Pharmaceuticals Ltd. Should Contact The Gross Law Firm Before January 9, 2026 to Discuss Your Rights - TLX

Mon, 05 Jan 2026 08:36:00 -0500 - 3 months ago

TELIX PHARMACEUTICALS (NASDAQ: TLX) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by January 9, 2026

Sun, 04 Jan 2026 12:00:00 -0500 - 3 months ago

TLX 5-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Dec 23, 2025, 1:12 PM EST - 3 months ago

TLX LAWSUIT DEADLINE: Hagens Berman Urges Telix Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain

Dec 22, 2025, 10:02 AM EST - 3 months ago

TLX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

Dec 21, 2025, 4:38 PM EST - 3 months ago

Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions

Dec 19, 2025, 9:43 AM EST - 3 months ago

TLX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

Dec 16, 2025, 3:30 PM EST - 3 months ago

Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately

Dec 15, 2025, 10:40 AM EST - 3 months ago

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

Dec 10, 2025, 7:00 AM EST - 4 months ago

Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration

Dec 2, 2025, 5:17 PM EST - 4 months ago

Telix Pharmaceuticals (TLX) Sued After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability – Hagens Berman

Nov 28, 2025, 5:25 PM EST - 4 months ago

Telix Pharmaceuticals (TLX) Sued After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman

Nov 28, 2025, 11:44 AM EST - 4 months ago

Bragar Eagel & Squire, P.C. Reminds Investors of Telix Pharmaceuticals and Firefly Aerospace to Contact the Firm About their Rights Before Lead Plaintiff Deadlines

FLY

Nov 24, 2025, 8:45 AM EST - 4 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of January 9, 2026 in Telix Pharmaceuticals Ltd. Lawsuit - TLX

Nov 23, 2025, 6:18 AM EST - 4 months ago

TLX INVESTOR REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

Nov 19, 2025, 2:00 PM EST - 4 months ago

ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses

Nov 5, 2025, 6:00 AM EST - 5 months ago

Telix to Participate in UBS and Jefferies Global Healthcare Conferences

Oct 23, 2025, 2:08 PM EDT - 5 months ago

Telix Pharmaceuticals Limited Investigated by the Portnoy Law Firm

Oct 22, 2025, 4:00 PM EDT - 5 months ago

Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain

Oct 15, 2025, 5:13 PM EDT - 6 months ago

TELIX INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Telix Pharmaceuticals Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Stockholders

Oct 14, 2025, 2:11 PM EDT - 6 months ago

Telix Pharmaceuticals Enters Q4 On Strong Footing With Stabilized Pricing Pressures, Upgraded Annual Sales Guidance

RadioIsotope25 Apr. 5 at 8:59 PM

0 · Reply

JFais Apr. 3 at 3:03 PM

$TLX (L) One of the slides we focused on for March double-down in $6's

0 · Reply

S144 Apr. 3 at 6:14 AM

$TLX 3 reasons to buy this red-hot ASX healthcare stock today: https://www.msn.com/en-au/health/healthy-lifestyle/3-reasons-to-buy-this-red-hot-asx-healthcare-stock-today/ar-AA1ZWnTW

0 · Reply

RadioIsotope25 Mar. 31 at 4:58 PM

Nuclear Radiopharma industry is hot. All of these stocks are strong buys imo. $RADX $TLX $LNTH $AKTS $CATX

1 · Reply

JFais Mar. 28 at 1:18 PM

$TLX (L) From Weekly Recap

0 · Reply

RadioIsotope25 Mar. 27 at 1:31 AM

1 · Reply

Cacaos Mar. 26 at 2:37 AM

$TLX 🤩

0 · Reply

alsworthg Mar. 24 at 2:53 PM

$RADX $AKTS $CATX $LNTH $TLX

0 · Reply

RadioIsotope25 Mar. 24 at 2:46 PM

Webinar Registration - Zoom $RADX $AKTS $CATX $LNTH $TLX https://us02web.zoom.us/webinar/register/WN_Uy9zCUEhQUaMqC1rYG5Zhw#/registration

0 · Reply

RadioIsotope25 Mar. 22 at 5:41 PM

Regarding RAD101 “tumors light up. We are at the cusp of a Theranostics revolution. $RADX $TLX $LNTH $AKTS

0 · Reply

RadioIsotope25 Mar. 21 at 8:30 PM

RAD101 upcoming phase 2b data potentially unlocks $RADX against its peers $TLX $LNTH and potentially re-rates stock. Estimated phase 2b completion March 31st, 2026…

1 · Reply

50bps Mar. 20 at 1:46 PM

$TLX 👀

0 · Reply

RadioIsotope25 Mar. 18 at 11:10 PM

$TLX

0 · Reply

americanpsycho42 Mar. 18 at 8:40 AM

$TLX this stock is so underrated

0 · Reply

AlertsAndNews Mar. 15 at 9:55 PM

$TLX Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate NDA back in the FDA hands here. "today announces the resubmission of a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX101-Px, (Pixclara®1, Floretyrosine F 18 or 18F-FET), an investigational PET2 imaging agent for the characterization of recurrent or progressive glioma (brain cancer) from treatment related changes in both adult and pediatric patients."

0 · Reply

GreenTeaKor Mar. 10 at 5:48 AM

$TLX hello?

0 · Reply

prismmarketview Feb. 25 at 7:12 PM

TelixPharma We’ve added Telix Pharmaceuticals Limited (NASDAQ: $TLX) to the PRISM Pharmaceuticals Index. With over $800M in 2025 revenue and multiple late-stage oncology programs advancing, Telix represents a rare disease and precision radiopharmaceutical story with significant clinical and regulatory catalysts ahead. Buy-rated with a $20 price target, TLX remains a name to watch in 2026 as key Phase 3 data and regulatory milestones unfold. https://prismmarketview.com/companies/telix-pharmaceuticals-limited/

0 · Reply

erevnon Feb. 24 at 7:28 PM

Citigroup maintains Telix Pharmaceuticals $TLX at Buy and raises the price target from $22 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

DailyAnalysis Feb. 24 at 6:28 PM

Post-earnings strength has $TLX clearing key 1D moving averages. 1W RSI is finally curling up from oversold levels, while 4H and 30M CCI remain bullish as STOCH enters the upper quintile during this recovery. @DailyAnalysis

0 · Reply

DailyAnalysis Feb. 23 at 3:36 PM

0 · Reply

BillionerOfKing Feb. 23 at 2:30 PM

$TLX Current Stock Price: $6.88

0 · Reply

DailyAnalysis Feb. 22 at 4:55 PM

0 · Reply

Market Cap	3.09B
Revenue (ttm)	803.79M
Net Income (ttm)	-7.13M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	105.60
Profit Margin	-0.89%
Debt to Equity Ratio	0.98

Volume	170,200
Avg Vol	264,198
Day's Range	N/A - N/A
Shares Out	338.89M
Stochastic %K	53%
Beta	-0.86
Analysts	Strong Sell
Price Target	$20.90